Home › Anemia
Pag-aaral pangklinika para sa Anemia na nagre-recruit sa U.S.
29 pag-aaral para sa Anemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY7 pag-aaral
- Atlanta, GA6 pag-aaral
- Miami, FL6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Tampa, FL5 pag-aaral
- Houston, TX5 pag-aaral
- Baldwin Park, CA4 pag-aaral
- Winston-Salem, NC4 pag-aaral
- Cleveland, OH4 pag-aaral
- St. Louis, MO4 pag-aaral
- Washington, DC3 pag-aaral
- Los Angeles, CA3 pag-aaral
- Seattle, WA3 pag-aaral
- Edison, NJ3 pag-aaral
- Gilbert, AZ3 pag-aaral
- Portland, OR3 pag-aaral
- Queens, NY3 pag-aaral
- Nashville, TN3 pag-aaral
- The Woodlands, TX3 pag-aaral
- Orlando, FL3 pag-aaral
Ayos sa estado
- Arizona4 pag-aaral
- California8 pag-aaral
- Florida9 pag-aaral
- Georgia7 pag-aaral
- Maryland3 pag-aaral
- Minnesota3 pag-aaral
- Missouri6 pag-aaral
- New Jersey3 pag-aaral
- New York11 pag-aaral
- North Carolina5 pag-aaral
- Ohio6 pag-aaral
- Oregon3 pag-aaral
- Pennsylvania7 pag-aaral
- Tennessee4 pag-aaral
- Texas7 pag-aaral
- Washington3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198Study of DISC-0974-201 in Participants With IBD and Anemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07368972A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07422480A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07623161A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06499285A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
Nagre-recruitObservasyonal na pag-aaral
1 Month – 100 Years · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06092346T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Nagre-recruitPhase 1/2
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06934967Choline and Iron Deficiency
Nagre-recruitPhase 2/3
5 Months – 7 Months · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06527391Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT07224360A Study of Luspatercept in People With Anemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07725497Kids With Iron Deficiency and Scoliosis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 10 hanggang 26 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06042699Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06106269131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Nagre-recruitPhase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT07015684Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Nagre-recruitPhase 2
3 Days · Lahat ng kasarian · Na-update May 26, 2026 · NCT05340465Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05800600Therapeutic RSK1 Targeting in Myelofibrosis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT07379125Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 4, 2026 · NCT07281781A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT03893045Diamond Blackfan Anemia Registry (DBAR)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT00106015Luspatercept for Clonal Cytopenias of Uncertain Significance
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06788691Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Kababaihan · Na-update Peb 18, 2026 · NCT06979492The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT06606119129Xe MRI Cardiopulmonary
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT06038630A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 30, 2025 · NCT05735314Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.